Communiqués Strides Pharma Science Limited Bombay S.E.

Actions

STAR

INE939A01011

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:53 16/07/2026			Varia. 5j.	Varia. 1 janv.
1 050,90 ^INR	-1,07%		-2,66%	+16,46%

18/05	Strides Pharma Science Limited publie ses résultats pour le quatrième trimestre clos le 31 mars 2026	CI
18/05	Transcript : Strides Pharma Science Limited, Q4 2026 Earnings Call, May 18, 2026

Communiqués

17/03	India's Strides Pharma expands Africa footprint with $12mn Sandoz generics deal	AQ
27/10/25	Strides Pharma Science : Intimation on Board Meeting scheduled for Oct 31, 2025	PU
24/07/25	Strides Pharma Science : Intimation of Board Meeting scheduled on July 29, 2025	PU
16/05/25	Strides Pharma Science : Intimation on Board Meeting scheduled for May 22, 2025	PU
27/01/25	Strides Pharma Science : Intimation of Board Meeting scheduled on January 30, 2025	PU
29/11/24	Strides Pharma Consolidates European Business-to-Business Operations in Switzerland	AQ
29/11/24	NAFDAC Raises Alarm Over Fake Anti-Malarial Medicine	AQ
18/10/24	Strides Pharma Science : Intimation of Board Meeting scheduled on October 24, 2024	PU
23/07/24	Strides Pharma Science : Intimation of Board Meeting scheduled on July 29, 2024	PU
14/05/24	Strides Pharma Science : Intimation of Board Meeting scheduled on May 22, 2024	PU
06/11/23	First African-Manufactured Combination Therapy For Seasonal Malaria Chemoprevention Receives WHO Prequalification [press release]	AQ
21/09/23	Strides Pharma Science : Intimation of Board Meeting scheduled on Sept 25, 2023	PU
26/07/23	Strides Pharma Science : Intimation of Board Meeting scheduled on August 2, 2023	PU
19/05/23	Strides Pharma Science : Intimation of Board Meeting scheduled on May 25, 2023	PU
09/02/23	Strides Pharma Science : Earnings Update_Q2FY23	PU
24/01/23	Strides Pharma Science : Earnings Update_Q3FY23	PU
19/01/23	Stelis Biopharma's flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products	AQ
17/01/23	Strides Pharma Science : Intimation of Board Meeting scheduled on January 24, 2023	PU
16/09/22	Strides Pharma Science : Share Warrants	PU
16/06/22	Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation	AQ
22/03/22	Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer's COVID-19 Oral Treatment across 95 markets	AQ
17/03/22	Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries	BU
15/03/22	Strides Pharma Science : Newspaper Advertisements	PU
14/03/22	Strides Pharma Science : Extra Ordinary Meeting	PU
11/02/22	Strides Pharma Science reports Q3 and 9M FY22 results	AQ